U.S. In Vitro Fertilization Market Size, Share & Trends Analysis Report By Instrument (Disposable Devices, Capital Equipment) By Procedure Type (Fresh Donor, Frozen Donor) By End-use, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Instrument
                        1.2.2. Procedure type
                        1.2.3. End-use
                        1.2.4. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Volume price analysis (Model 2)
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Instrument outlook
                        2.2.2. Procedure type
                        2.2.3. End-use
                    2.3. Competitive Insights
Chapter 3. U.S. In Vitro Fertilization Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                        3.2.2. Market restraint analysis
                    3.3. U.S. In Vitro Fertilization Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
Chapter 4. U.S. In Vitro Fertilization Market: Instrument Estimates & Trend Analysis
                    4.1. Instrument Market Share, 2023 & 2030
                    4.2. Segment Dashboard
                    4.3. U.S. In Vitro Fertilization Market by Instrument Outlook
                    4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
                        4.4.1. Disposable media
                            4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.2. Culture media
                            4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.2.2. Cryopreservation Media
                                4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.2.3. Embryo culture media
                                4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.2.4. Ovum Processing Media
                                4.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.2.5. Sperm Processing Media
                                4.4.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.3. Capital Equipment
                            4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.3.2. Sperm Analyzer Systems
                                4.4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.3.3. Imaging Systems
                                4.4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.3.4. Ovum Aspiration Pumps
                                4.4.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.3.5. Micromanipulator Systems
                                4.4.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.3.6. Incubators
                                4.4.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.3.7. Gas Analyzers
                                4.4.3.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.3.8. Laser Systems
                                4.4.3.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.3.9. Cryosystems
                                4.4.3.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.3.10. Sperm Separation Devices
                                4.4.3.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.3.11. IVF Cabinets
                                4.4.3.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.3.12. Anti-vibration Tables
                                4.4.3.12.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.3.13. Witness Systems
                                4.4.3.13.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                            4.4.3.14. Other
                                4.4.3.14.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. U.S. In Vitro Fertilization Market: Procedure Type Estimates & Trend Analysis
                    5.1. Procedure Type Market Share, 2023 & 2030
                    5.2. Segment Dashboard
                    5.3. U.S. In Vitro Fertilization Market by Procedure Type Outlook
                    5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
                        5.4.1. Fresh Donor
                            5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.4.2. Frozen Donor
                            5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.4.3. Fresh Non-donor
                            5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        5.4.4. Frozen Non-donor
                            5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. U.S. In Vitro Fertilization Market: End-use Estimates & Trend Analysis
                    6.1. End-use Market Share, 2023 & 2030
                    6.2. Segment Dashboard
                    6.3. U.S. In Vitro Fertilization Market by End-use Outlook
                    6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
                        6.4.1. Fertility Clinics
                            6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        6.4.2. Hospitals & Others Setting
                            6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
                    7.1. Recent Developments & Impact Analysis, By Key Market Participants
                    7.2. Company/Competition Categorization
                    7.3. Vendor Landscape
                        7.3.1. List of key distributors and channel partners
                        7.3.2. Key customers
                        7.3.3. Key company heat map analysis, 2023
                    7.4. Company Profiles
                        7.4.1. Bayer AG
                            7.4.1.1. Company overview
                            7.4.1.2. Financial performance
                            7.4.1.3. Product benchmarking
                            7.4.1.4. Strategic initiatives
                        7.4.2. Cook Medical LLC
                            7.4.2.1. Company overview
                            7.4.2.2. Financial performance
                            7.4.2.3. Product benchmarking
                            7.4.2.4. Strategic initiatives
                        7.4.3. EMD Serono, Inc.
                            7.4.3.1. Company overview
                            7.4.3.2. Financial performance
                            7.4.3.3. Product benchmarking
                            7.4.3.4. Strategic initiatives
                        7.4.4. Ferring B.V.
                            7.4.4.1. Company overview
                            7.4.4.2. Financial performance
                            7.4.4.3. Product benchmarking
                            7.4.4.4. Strategic initiatives
                        7.4.5. FUJIFILM Irvine Scientific (FUJIFILM Holdings Corporation)
                            7.4.5.1. Company overview
                            7.4.5.2. Financial performance
                            7.4.5.3. Product benchmarking
                            7.4.5.4. Strategic initiatives
                        7.4.6. Genea Biomedx
                            7.4.6.1. Company overview
                            7.4.6.2. Financial performance
                            7.4.6.3. Product benchmarking
                            7.4.6.4. Strategic initiatives
                        7.4.7. EMD Serono, Inc. (Merck KGaA)
                            7.4.7.1. Company overview
                            7.4.7.2. Financial performance
                            7.4.7.3. Product benchmarking
                            7.4.7.4. Strategic initiatives
                        7.4.8. Merck & Co., Inc.
                            7.4.8.1. Company overview
                            7.4.8.2. Financial performance
                            7.4.8.3. Product benchmarking
                            7.4.8.4. Strategic initiatives
                        7.4.9. The Cooper Companies, Inc.
                            7.4.9.1. Company overview
                            7.4.9.2. Financial performance
                            7.4.9.3. Product benchmarking
                            7.4.9.4. Strategic initiatives
                        7.4.10. Thermo Fisher Scientific, Inc.
                            7.4.10.1. Company overview
                            7.4.10.2. Financial performance
                            7.4.10.3. Product benchmarking
                            7.4.10.4. Strategic initiatives
                        7.4.11. Vitrolife
                            7.4.11.1. Company overview
                            7.4.11.2. Financial performance
                            7.4.11.3. Product benchmarking
                            7.4.11.4. Strategic initiatives
                        7.4.12. Nova IVF
                            7.4.12.1. Company overview
                            7.4.12.2. Financial performance
                            7.4.12.3. Product benchmarking
                            7.4.12.4. Strategic initiativesc
                        7.4.13. RMA Network (Reproductive Medicine Associates)
                            7.4.13.1. Company overview
                            7.4.13.2. Financial performance
                            7.4.13.3. Product benchmarking
                            7.4.13.4. Strategic initiatives
                        7.4.14. U.S. Fertility
                            7.4.14.1. Company overview
                            7.4.14.2. Financial performance
                            7.4.14.3. Product benchmarking
                            7.4.14.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 U.S. in vitro fertilization market, by instrument, 2018 - 2030 (USD Million)
Table 3 U.S. in vitro fertilization market, by procedure type, 2018 - 2030 (USD Million)
Table 4 U.S. in vitro fertilization market, by end - use, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. in vitro fertilization market: market outlook
Fig. 9 U.S. in vitro fertilization competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 U.S. in vitro fertilization market driver impact
Fig. 14 U.S. in vitro fertilization market restraint impact
Fig. 15 U.S. in vitro fertilization market: Instrument movement analysis
Fig. 16 U.S. in vitro fertilization market: Instrument outlook and key takeaways
Fig. 17 Radiofrequency ablation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Disposable devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Culture Media market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Cryopreservation media market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Embryo culture media market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Ovum processing media market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Sperm processing media market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Capital equipment market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Sperm analyzer systems market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Imaging systems market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Ovum aspiration pumps market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Micromanipulator market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Incubators market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Gas analyzers market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Laser systems market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Cryosystems market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Sperm separation devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 IVF cabinets market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Anti - vibration tables market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Witness systems market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 U.S. in vitro fertilization market: Procedure type movement Analysis
Fig. 39 U.S. in vitro fertilization market: Procedure type outlook and key takeaways
Fig. 40 Surgical ablation market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Fresh donor market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Frozen donor market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Fresh non - donor market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Frozen non - donor market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 U.S. in vitro fertilization market: End - use outlook and key takeaways
Fig. 46 Fertility clinics market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Hospitals and other settings market estimates and forecasts, 2018 - 2030 (USD Million)